Invicta Diagnostic Limited INVICTAshare price and chart
Invicta Diagnostic closed at ₹77.00 on 18 November 2026, down 2.41% on the day. The 52-week range is ₹58.10 to ₹105.00.
Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.
Loading prices…
Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.Test a strategy on INVICTA
Real prices, every charge counted. Pick one or write your own.Invicta Diagnostic provides diagnostic services including MRI, CT, PET-CT, X-ray and sonography imaging, pathology tests, integrated diagnostics and teleradiology, through its own centres and subsidiaries in a hub and spoke model.
Healthcare Services
Radiology, pathology, teleradiology
Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.
EOD 18 NovThe share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Returns and valuationWhat the market pays for this company and how well the business uses its money.
Books to 30 Sept 2026Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.
Who owns itEach line is that holder's share of all shares over the last 3 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.
The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.
Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.
Last 6 monthsKey ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.
Against its sectorPeers are the listed companies in the exchange's own industry group: Healthcare Service Provider. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.
Month by month| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -18.7 | -3.9 | +1.6 | +58.5 | -34.1 | +1.9 | +1.7 | +0.6 | -1.5 | -4.4 | +19.4 | · | -2.9% 11m |
Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.
Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.
| Date | Party | Side | Quantity | Price | Value |
|---|---|---|---|---|---|
| 2026-08-05 | PINE OAK GLOBAL FUND · bulk | SELL | 1,93,600 | ₹73.79 | ₹1.43 Cr |
| 2026-08-05 | BIRCHWOOD MULTI STGY FND OPENENDED PCC LTD - BIRCHWOOD GLOBAL ALPHA FUND · bulk | BUY | 1,93,600 | ₹73.79 | ₹1.43 Cr |
| 2026-03-27 | RGSL INVESTMENT LVF 1 · bulk | BUY | 84,800 | ₹66.00 | ₹0.56 Cr |
| 2026-03-23 | RGSL INVESTMENT LVF 1 · bulk | BUY | 1,21,600 | ₹67.50 | ₹0.82 Cr |
| 2026-03-19 | NIHAR AMIT DAVE · bulk | BUY | 1,50,400 | ₹76.00 | ₹1.14 Cr |
| 2026-03-19 | NEERAJ VISHNUKUMAR GUPTA · bulk | SELL | 1,15,200 | ₹76.00 | ₹0.88 Cr |
| 2026-03-05 | INVESTI GLOBAL OPPORTUNITY FUND PCC - CELL 1 · bulk | BUY | 1,20,000 | ₹70.44 | ₹0.85 Cr |
| 2026-02-12 | PINE OAK GLOBAL FUND · bulk | BUY | 1,60,000 | ₹69.00 | ₹1.10 Cr |
- Board outcomeOutcome of Board Meeting14 Nov 2026
Invicta Diagnostic Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
- Board outcomeOutcome of Board Meeting14 Nov 2026
Invicta Diagnostic Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
- Board outcomeOutcome of Board Meeting18 May 2026
Invicta Diagnostic Limited has submitted to the Exchange, the standalone and consolidated financial results for the period ended March 31, 2026.
The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.
Read enough? Test INVICTA. “Buy INVICTA when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.
Run it free